Literature DB >> 24184997

Zinc plays a critical role in the cardioprotective effect of postconditioning by enhancing the activation of the RISK pathway in rat hearts.

Zhelong Xu1, Seokjae Kim2, Jin Huh3.   

Abstract

This study investigated if zinc plays a role in postconditioning-induced cardioprotection in rat hearts. Isolated rat hearts were subjected to 30 min regional ischemia followed by 2h of reperfusion. Postconditioning was elicited by 6 cycles of 10s reperfusion and 10s ischemia. Cytosolic zinc concentrations were measured with inductively coupled plasma optical emission spectroscopy (ICPOES). Infarct size was assessed by triphenyltetrazolium chloride staining. Cytosolic zinc concentrations were decreased dramatically upon reperfusion in the control hearts. In contrast, postconditioning increased cytosolic zinc levels at reperfusion. The anti-infarct effect of postconditioning was inhibited by the selective zinc chelator N,N,N',N'-tetrakis-(2-pyridylmethyl) ethylenediamine (TPEN). Postconditioning significantly increased phosphorylation levels of the reperfusion injury salvage kinases (RISK) including Akt (Ser(473)), extracellular signal-regulated kinase1/2 (ERK1/2) (Thr(202)/Tyr(204)), and glycogen synthase kinase-3β (GSK-3β) (Ser(9)) at reperfusion, which were nullified by TPEN. Postconditioning decreased the activity of protein phosphatase 2A (PP2A) in a zinc-dependent manner. Knockdown of the zinc transporter Zip2 inhibited the protective effect of postconditioning on hypoxia/reoxygenation injury in H9c2 cells. These results suggest that zinc plays an important role in the cardioprotective effect of postconditioning presumably by enhancing the activation of the RISK pathway. Zip2 and inactivation of PP2A by zinc may, at least in part, account for the activation of the RISK pathway.
© 2013.

Entities:  

Keywords:  Ischemic postconditioning; PP2A; The RISK pathway; Zinc

Mesh:

Substances:

Year:  2013        PMID: 24184997     DOI: 10.1016/j.yjmcc.2013.10.016

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  9 in total

Review 1.  Zinc-Based Biomaterials for Regeneration and Therapy.

Authors:  Yingchao Su; Irsalan Cockerill; Yadong Wang; Yi-Xian Qin; Lingqian Chang; Yufeng Zheng; Donghui Zhu
Journal:  Trends Biotechnol       Date:  2018-11-21       Impact factor: 19.536

2.  Effect of zinc supplements in the attenuated cardioprotective effect of ischemic preconditioning in hyperlipidemic rat heart.

Authors:  Sunil Kumar Kansal; Uma Jyoti; Samridhi Sharma; Arun Kaura; Rahul Deshmukh; Sandeep Goyal
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-03-07       Impact factor: 3.000

Review 3.  p66Shc in Cardiovascular Pathology.

Authors:  Landon Haslem; Jennifer M Hays; Franklin A Hays
Journal:  Cells       Date:  2022-06-06       Impact factor: 7.666

4.  Acute administration of n-3 rich triglyceride emulsions provides cardioprotection in murine models after ischemia-reperfusion.

Authors:  Hylde Zirpoli; Mariane Abdillahi; Nosirudeen Quadri; Radha Ananthakrishnan; Lingjie Wang; Rosa Rosario; Zhengbin Zhu; Richard J Deckelbaum; Ravichandran Ramasamy
Journal:  PLoS One       Date:  2015-01-05       Impact factor: 3.240

Review 5.  Zinc deficiency and cellular oxidative stress: prognostic implications in cardiovascular diseases.

Authors:  Sangyong Choi; Xian Liu; Zui Pan
Journal:  Acta Pharmacol Sin       Date:  2018-06-21       Impact factor: 6.150

6.  No Association of Hair Zinc Concentration with Coronary Artery Disease Severity and No Relation with Acute Coronary Syndromes.

Authors:  Ewelina A Dziedzic; Jakub S Gąsior; Agnieszka Tuzimek; Justyna Paleczny; Mirosław Kwaśny; Marek Dąbrowski; Piotr Jankowski
Journal:  Biomolecules       Date:  2022-06-21

7.  Ion Therapy: A Novel Strategy for Acute Myocardial Infarction.

Authors:  Min Yi; Hekai Li; Xiaoya Wang; Jianyun Yan; Long Gao; Yinyan He; Xinglong Zhong; Yanbin Cai; Weijing Feng; Zhanpeng Wen; Chengtie Wu; Caiwen Ou; Jiang Chang; Minsheng Chen
Journal:  Adv Sci (Weinh)       Date:  2018-11-08       Impact factor: 16.806

Review 8.  The Rationale of Neprilysin Inhibition in Prevention of Myocardial Ischemia-Reperfusion Injury during ST-Elevation Myocardial Infarction.

Authors:  Alessandro Bellis; Ciro Mauro; Emanuele Barbato; Giuseppe Di Gioia; Daniela Sorriento; Bruno Trimarco; Carmine Morisco
Journal:  Cells       Date:  2020-09-21       Impact factor: 6.600

Review 9.  Nutraceuticals in Chronic Coronary Syndromes: Preclinical Data and Translational Experiences.

Authors:  Chiara Tognola; Maloberti Alessandro; Martina Milani; Iside Cartella; Giovanni Tavecchia; Enzo Grasso; Jinwey Sun; Cristina Giannattasio
Journal:  High Blood Press Cardiovasc Prev       Date:  2020-10-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.